Hertzberg Richard

Average Profitability
<0.0001%
Insider Buys Quantity
12
Insider Buys Sum
$3.3M
Insider Sells Quantity
1
Insider Sells Sum
$42,609.00

Insider Activity of Hertzberg Richard

The largest purchase of all time was on 2014-08-20 and amounted to 409158 shares of Cellectar Biosciences, Inc. for $1.53M.

The largest sale of all time was on 2016-10-31 and amounted to 21000 shares of Cellectar Biosciences, Inc. for $42,609.

Biography of Hertzberg Richard

No biography is available at this moment.

2016-10-31SaleCellectar Biosciences, Inc.
CLRB
21,000
0.1919%
$2.03$42,609-9.19%
2016-04-21PurchaseCellectar Biosciences, Inc.
CLRB
7,516
0.1746%
$1.90$14,280+21.69%
2016-04-15PurchaseCellectar Biosciences, Inc.
CLRB
469,484
13.3261%
$2.58$1.21M+9.52%
2015-12-28PurchaseCellectar Biosciences, Inc.
CLRB
significant owner
75,000
0.899%
$0.72$54,000-60.71%
2015-12-24PurchaseCellectar Biosciences, Inc.
CLRB
significant owner
50,000
0.5683%
$0.79$39,500-65.99%
2015-12-22PurchaseCellectar Biosciences, Inc.
CLRB
significant owner
5,000
0.0576%
$0.91$4,550-70%
2015-12-16PurchaseCellectar Biosciences, Inc.
CLRB
significant owner
19,592
0.2361%
$0.91$17,829-67.5%
2015-12-11PurchaseCellectar Biosciences, Inc.
CLRB
significant owner
16,250
0.1988%
$0.92$15,015-66.48%
2015-12-08PurchaseCellectar Biosciences, Inc.
CLRB
significant owner
10,000
1.6054%
$12.00$120,000-65.63%
2014-10-03PurchaseCellectar Biosciences, Inc.
CLRB
significant owner
10,000
1.2385%
$12.00$120,000+34.83%
2014-09-19PurchaseCellectar Biosciences, Inc.
CLRB
significant owner
20,000
0.4036%
$2.67$53,400+7.58%
2014-08-20PurchaseCellectar Biosciences, Inc.
CLRB
significant owner
409,158
9.9072%
$3.75$1.53M-8.25%
2011-12-05PurchaseCellectar Biosciences, Inc.
CLRB
significant owner
10,000
0.5417%
$12.00$120,000+91.67%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.